Finance 

Relief Therapeutics (RLFTF) Consolidates After The Recent Uptrend: What Next?

Alex Krakowsky

Relief Therapeutics (OTC: RLFTF) may not be a particularly well-known company but in recent times the company has seen its stock make considerable due to its work on a coronavirus medicine.

Relief Therapeutics (RLFTF) Consolidates After The Recent Uptrend: What Next?

The biopharmaceutical company is working on a product named RLF 100 which is meant for treating and currently it is at an advanced stage. Relief is collaborating with NeuroRx for the development of the product and back in February, there was a positive announcement. Hence, it was no surprise that the stock Relief stock jumped considerably on the back of the announcement, and over the past days, the stock has been in consolidation mode.

The product, which is meant for treating patients suffering from severe symptoms of COVID 19, showed positive effects on patients in the Phase 2b/3 trial. Considering the fact that the coronavirus pandemic is far from over, it might be a good idea for investors to keep a closer eye on the Relief stock over the coming days.

Alex Krakowsky

Editor in Chief.Living in the era of dynamic tech change Alex decided to stay tuned in changes that make any person find comfort and adapt to new devices. Furthermore, gaming became his passion for spending leisure time with his close ones. Although, he has a degree in Business Administration (majoring in Finance) writing for technology and as well as finance has been one of the precious aspects of his life